awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37719944-BF2DFE37-E032-4FBA-845E-0A747BBF7687
Q37719944-BF2DFE37-E032-4FBA-845E-0A747BBF7687
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37719944-BF2DFE37-E032-4FBA-845E-0A747BBF7687
TRAIL combinations: The new 'trail' for cancer therapy (Review).
P2860
Q37719944-BF2DFE37-E032-4FBA-845E-0A747BBF7687
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37719944-BF2DFE37-E032-4FBA-845E-0A747BBF7687
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfe49c84333cd6a3146029bd5e44fdfb4d4d7c66
P2860
Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.